Literature DB >> 31065369

MiR-4319 suppresses colorectal cancer progression by targeting ABTB1.

Longchang Huang1, Ye Zhang2, Zengyao Li2, Xiaoqian Zhao1, Zhong Xi1,2, Hang Chen1, Haoze Shi1, Taojian Xin1, Renhui Shen1, Tong Wang1,2.   

Abstract

Background: Colorectal cancer is one of the highly malignant cancers with a poor prognosis. The exact mechanism of colorectal cancer progression is not completely known. Recently, microRNAs (miRNAs, miRs) were suggested to participate in the regulation of multiple cancer development, including colorectal cancer.
Methods: MiR-4319 expression in colorectal cancer patient samples was detected by real-time polymerase chain reaction. MiR-4319 was knocked down in the colorectal cancer cells by siRNA transfection to study the role of miR-4319 in the cell cycle and proliferation of colorectal cancer cells.
Results: MiR-4319 expression was found to be inverse correlated with survival in colorectal cancer patients. Overexpression of miR-4319 markedly reduced the proliferation of colorectal cancer cells and altered cell cycle distribution. A further experiment showed that ABTB1 is the target gene of miR-4319. MiR-4319 was regulated by PLZF.
Conclusion: Our studies indicated that reduced expression of miR-4319 was correlated with poor prognosis in colorectal cancer patients; miR-4319 also suppressed colorectal cancer cell proliferation by targeting ABTB1. ABTB1 might become an excellent therapeutic target for colorectal cancer treatment.

Entities:  

Keywords:  ABTB1; Colorectal cancer; PLZF; miR-4319

Mesh:

Substances:

Year:  2019        PMID: 31065369      PMCID: PMC6488794          DOI: 10.1177/2050640619837440

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  28 in total

1.  MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers.

Authors:  Yukihiro Akao; Yoshihito Nakagawa; Tomoki Naoe
Journal:  Oncol Rep       Date:  2006-10       Impact factor: 3.906

2.  p15RS/RPRD1A (p15INK4b-related sequence/regulation of nuclear pre-mRNA domain-containing protein 1A) interacts with HDAC2 in inhibition of the Wnt/β-catenin signaling pathway.

Authors:  Chunxiao Liu; Yanquan Zhang; Jun Li; Yinyin Wang; Fangli Ren; Yifan Zhou; Yinyuan Wu; Yarui Feng; Yu Zhou; Fuqin Su; Baoqing Jia; Dong Wang; Zhijie Chang
Journal:  J Biol Chem       Date:  2015-02-19       Impact factor: 5.157

3.  Re-expression of microRNA-4319 inhibits growth of prostate cancer via Her-2 suppression.

Authors:  X Lin; Y Wang
Journal:  Clin Transl Oncol       Date:  2018-04-09       Impact factor: 3.405

4.  Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro.

Authors:  Jun Deng; Wan Lei; Jian-Chun Fu; Ling Zhang; Jun-He Li; Jian-Ping Xiong
Journal:  Biochem Biophys Res Commun       Date:  2013-11-23       Impact factor: 3.575

5.  MiR-1 suppresses tumor cell proliferation in colorectal cancer by inhibition of Smad3-mediated tumor glycolysis.

Authors:  Wanfu Xu; Zijing Zhang; Kejian Zou; Yang Cheng; Min Yang; Huan Chen; Hongli Wang; Junhong Zhao; Peiyu Chen; Liying He; Xinwen Chen; Lanlan Geng; Sitang Gong
Journal:  Cell Death Dis       Date:  2017-05-04       Impact factor: 8.469

6.  PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2.

Authors:  Hui Shen; Ming Zhan; Yonglong Zhang; Shuai Huang; Sunwang Xu; Xince Huang; Min He; Yanhua Yao; Mohan Man; Jian Wang
Journal:  Cell Death Dis       Date:  2018-01-22       Impact factor: 8.469

7.  The Novel Toll-Like Receptor 2 Agonist SUP3 Enhances Antigen Presentation and T Cell Activation by Dendritic Cells.

Authors:  Xueheng Guo; Ning Wu; Yingli Shang; Xin Liu; Tao Wu; Yifan Zhou; Xin Liu; Jiaoyan Huang; Xuebin Liao; Li Wu
Journal:  Front Immunol       Date:  2017-02-21       Impact factor: 7.561

8.  Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis.

Authors:  Xian-Guo Zhou; Xiao-Liang Huang; Si-Yuan Liang; Shao-Mei Tang; Si-Kao Wu; Tong-Tong Huang; Zeng-Nan Mo; Qiu-Yan Wang
Journal:  Onco Targets Ther       Date:  2018-05-15       Impact factor: 4.147

9.  Identity, community and care in online accounts of hereditary colorectal cancer syndrome.

Authors:  Emily Ross; Tineke Broer; Anne Kerr; Sarah Cunningham-Burley
Journal:  New Genet Soc       Date:  2018-05-02

Review 10.  MicroRNAs as Biomarkers in Colorectal Cancer.

Authors:  Takaaki Masuda; Naoki Hayashi; Yosuke Kuroda; Shuhei Ito; Hidetoshi Eguchi; Koshi Mimori
Journal:  Cancers (Basel)       Date:  2017-09-13       Impact factor: 6.639

View more
  15 in total

1.  Long non-coding RNA HOXA-AS3 facilitates the malignancy in colorectal cancer by miR-4319/SPNS2 axis.

Authors:  Yang Jiang; Xiao-Yu Yu; Hui-Xin Sun; Xin-Yue Gu; Jing-Shu Geng
Journal:  J Physiol Biochem       Date:  2021-10-21       Impact factor: 4.158

2.  Effects of laparoscopic radical surgery in the treatment of colorectal cancer and correlations of VEGF and TGF-β1 with prognosis.

Authors:  Chuan-Peng Sun; Yan Bai; Jin-Qiang Jiang; Jian-Lin Wu
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

3.  Circ_0003266 sponges miR-503-5p to suppress colorectal cancer progression via regulating PDCD4 expression.

Authors:  Caihong Wen; Xiaoqing Feng; Honggang Yuan; Yong Gong; Guangsheng Wang
Journal:  BMC Cancer       Date:  2021-03-16       Impact factor: 4.430

4.  Long non-coding RNA LINC00426 contributes to doxorubicin resistance by sponging miR-4319 in osteosarcoma.

Authors:  Lulin Wang; Yi Luo; Yiquan Zheng; Lifeng Zheng; Wenxiang Lin; Zonglin Chen; Shichun Wu; Jinhong Chen; Yun Xie
Journal:  Biol Direct       Date:  2020-07-03       Impact factor: 4.540

5.  Immune-related genes in tumor-specific CD4+ and CD8+ T cells in colon cancer.

Authors:  Xi Yang; Wei Wu; Yuefen Pan; Qing Zhou; Jiamin Xu; Shuwen Han
Journal:  BMC Cancer       Date:  2020-06-22       Impact factor: 4.430

6.  MiR-506 Targets UHRF1 to Inhibit Colorectal Cancer Proliferation and Invasion via the KISS1/PI3K/NF-κB Signaling Axis.

Authors:  Yilin Lin; Zhihua Chen; Yan Zheng; Yisu Liu; Ji Gao; Suyong Lin; Shaoqin Chen
Journal:  Front Cell Dev Biol       Date:  2019-11-15

7.  MiR-4319 induced an inhibition of epithelial-mesenchymal transition and prevented cancer stemness of HCC through targeting FOXQ1.

Authors:  Shaoshan Han; Yu Shi; Liankang Sun; Zhikui Liu; Tao Song; Qingguang Liu
Journal:  Int J Biol Sci       Date:  2019-11-15       Impact factor: 6.580

8.  miR‑576‑5p promotes epithelial‑to‑mesenchymal transition in colorectal cancer by targeting the Wnt5a‑mediated Wnt/β‑catenin signaling pathway.

Authors:  Jialin Luo; Luying Liu; Jinwen Shen; Ning Zhou; Yanru Feng; Na Zhang; Quanquan Sun; Yuan Zhu
Journal:  Mol Med Rep       Date:  2020-12-10       Impact factor: 2.952

9.  MiR-3150b-3p inhibits the progression of colorectal cancer cells via targeting GOLPH3.

Authors:  Weiqing Zhang; Xiaoyan Chen; Junzhi Jia
Journal:  J Investig Med       Date:  2019-11-02       Impact factor: 2.895

10.  MicroRNA-934 facilitates cell proliferation, migration, invasion and angiogenesis in colorectal cancer by targeting B-cell translocation gene 2.

Authors:  Bo Li; Xianyi Liu; Guogang Wu; Jiawen Liu; Shouliang Cai; Fuxin Wang; Chunyu Yang; Jisheng Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.